Skip to main content

Table 8 SUCRA ranking of FVC (L) absolute change from baseline

From: A comprehensive comparison of the safety and efficacy of drugs in the treatment of idiopathic pulmonary fibrosis: a network meta-analysis based on randomized controlled trials

Treatment

SUCRA

PrBest

MeanRank

Warfarin

85.2

33.8

2.3

Imatinib

73.2

17.8

3.4

Placebo

72.6

2.4

3.5

Macitentan

61.3

32.9

4.5

Bosentan

54.8

8.2

5.1

N-acetylcysteine

47.1

2.5

5.8

Nintedanib

36.2

0

6.7

GLPG1690

34

1.6

6.9

PRM151

22.7

0.1

8

Pamrevlumab

13

0.7

8.8

  1. Higher values of SUCRA indicate higher values of decline in FVC (L) absolute change from baseline
Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us